Back to Schemes

NGS for somatic SNVs and indels – tumour with germline subtraction analysis

Product Code: 03-NGSS-PLM-26

From £745.00

Deadline to order: 28/02/2026

EQA for quality of NGS for somatic SNVs and indels <50bp (FFPE). For NGS requiring a matched normal control germline sample (single gene, panel testing, whole exome sequencing or whole genome sequencing). Pilot EQA.

Target/Genes:

Participating laboratories can use any NGS strategy to participate (single gene, panel testing, whole exome sequencing or whole genome sequencing). This EQA scheme includes a matched germline normal sample for laboratories that use germline variant subtraction.  The scheme will assess all single nucleotide variants and indels 50bp or less in size.Participants will be asked what NGS strategy they are likely to use in participation (single gene, panel testing, whole exome sequencing or whole genome sequencing or both) at the point of purchase. Please contact us at office@emqn.org if your needs change or with any queries.  

Technology:

NGS, Whole exome sequencing, Whole genome sequencing

Language:

Not applicable

Sample Type:

DNA (in TE Buffer)

Accredited:

No

Sample Dispatch Date:

September 2026

Survey Period:

September - November 2026

You can complete purchase on our secure partner site.

EQA Assessment

This EQA scheme is NOT suitable for somatic NGS workflows that DO NOT require a matched normal control sample. Please see our DNA SEQUENCING – NGS (Somatic – no matched germline sample) EQA scheme.

Sample Details

One mock clinical case with matching tumour DNA and germline DNA samples will be provided. Approximately 1-2µg DNA per sample is provided depending on testing strategy. Complete information will be available in the scheme instructions. Laboratories will be contacted prior to sample dispatch to obtain testing strategy for sample requirements.

EQA Results

 Participants will receive a comprehensive individual data quality report and a variant consensus analysis report for each submission. A comprehensive summary scheme report is provided including additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Participation Information

Participants are expected to test samples according to their routine NGS strategy, to submit VCF, BED, FASTQ and BAM files for analysis.

Laboratories can submit up to three different SNV / indel data sets per participation, derived from different analyses of the EQA sample (e.g. different panels or methodologies).

No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc). This EQA is provided in collaboration with GenQA. 

How it works

Register

  • Enrol before the closing date
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via your website account

Review & get certified

  • EMQN assesses your data
  • Receive your individual results, EQA summary report & certificate of participation

Enquire about this scheme

Contact Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.